484 related articles for article (PubMed ID: 30918424)
41. Significance of preoperative fluorodeoxyglucose-positron emission tomography in prediction of tumor recurrence after liver transplantation for hepatocellular carcinoma patients: a Japanese multicenter study.
Takada Y; Kaido T; Shirabe K; Nagano H; Egawa H; Sugawara Y; Taketomi A; Takahara T; Wakabayashi G; Nakanishi C; Kawagishi N; Kenjo A; Gotoh M; Toyoki Y; Hakamada K; Ohtsuka M; Akamatsu N; Kokudo N; Takeda K; Endo I; Takamura H; Okajima H; Wada H; Kubo S; Kuramitsu K; Ku Y; Ishiyama K; Ohdan H; Ito E; Maehara Y; Honda M; Inomata Y; Furukawa H; Uemoto S; Yamaue H; Miyazaki M; Takada T;
J Hepatobiliary Pancreat Sci; 2017 Jan; 24(1):49-57. PubMed ID: 27806426
[TBL] [Abstract][Full Text] [Related]
42. Combining
Kornberg A; Witt U; Schernhammer M; Kornberg J; Ceyhan GO; Mueller K; Friess H; Thrum K
Sci Rep; 2017 Oct; 7(1):14176. PubMed ID: 29074969
[TBL] [Abstract][Full Text] [Related]
43. Clinical value of pre-and postoperative 18F-FDG PET/CT in patients undergoing liver transplantation for hepatocellular carcinoma.
Wang XL; Li H; Wang QS; Zhang XL
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1087-91, 1095. PubMed ID: 16939890
[TBL] [Abstract][Full Text] [Related]
44. Prognostic significance of parameters from pretreatment (18)F-FDG PET in hepatocellular carcinoma: a meta-analysis.
Sun DW; An L; Wei F; Mu L; Shi XJ; Wang CL; Zhao ZW; Li TF; Lv GY
Abdom Radiol (NY); 2016 Jan; 41(1):33-41. PubMed ID: 26830609
[TBL] [Abstract][Full Text] [Related]
45.
Na SJ; Oh JK; Hyun SH; Lee JW; Hong IK; Song BI; Kim TS; Eo JS; Lee SW; Yoo IR; Chung YA; Yun M
J Nucl Med; 2017 May; 58(5):730-736. PubMed ID: 27789714
[TBL] [Abstract][Full Text] [Related]
46. 18F-fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma.
Kim BK; Kang WJ; Kim JK; Seong J; Park JY; Kim DY; Ahn SH; Lee DY; Lee KH; Lee JD; Han KH
Cancer; 2011 Oct; 117(20):4779-87. PubMed ID: 21469082
[TBL] [Abstract][Full Text] [Related]
47. Incidentally found parotid gland lesion in
Jung JH; Lee YS; Jung YH; Choi SH; Nam SY; Cho HJ; Kwon M
BMC Surg; 2024 Apr; 24(1):124. PubMed ID: 38658868
[TBL] [Abstract][Full Text] [Related]
48. PET Imaging of Hepatocellular Carcinomas:
Zhao J; Zhang Z; Nie D; Ma H; Yuan G; Su S; Liu S; Liu S; Tang G
Mol Imaging; 2019; 18():1536012118821032. PubMed ID: 30799682
[TBL] [Abstract][Full Text] [Related]
49. [Value of (18)F-FDG PET/CT and CECT in detecting postoperative recurrence and extrahepatic metastasis of hepatocellular carcinoma in patients with elevated serum alpha-fetoprotein].
Chen Z; Liang H; Zhang X; Wang X; Chen W; Shi X; Yi C; Rao L
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Nov; 32(11):1615-9. PubMed ID: 23174588
[TBL] [Abstract][Full Text] [Related]
50. Identification of Keratin 19-Positive Cancer Stem Cells Associating Human Hepatocellular Carcinoma Using
Kawai T; Yasuchika K; Seo S; Higashi T; Ishii T; Miyauchi Y; Kojima H; Yamaoka R; Katayama H; Yoshitoshi EY; Ogiso S; Kita S; Yasuda K; Fukumitsu K; Nakamoto Y; Hatano E; Uemoto S
Clin Cancer Res; 2017 Mar; 23(6):1450-1460. PubMed ID: 27663597
[No Abstract] [Full Text] [Related]
51. Early diagnosis of recurrent hepatocellular carcinoma with 18F-FDG PET after radiofrequency ablation therapy.
Paudyal B; Oriuchi N; Paudyal P; Tsushima Y; Iida Y; Higuchi T; Hanaoka H; Miyakubo M; Takano A; Ishikita T; Endo K
Oncol Rep; 2007 Dec; 18(6):1469-73. PubMed ID: 17982632
[TBL] [Abstract][Full Text] [Related]
52. The clinical value of 18F-FDG PET/CT for investigating unexplained serum AFP elevation following interventional therapy for hepatocellular carcinom.
Han AR; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Hepatogastroenterology; 2009; 56(93):1111-6. PubMed ID: 19760952
[TBL] [Abstract][Full Text] [Related]
53. A pilot comparison of 18F-fluorodeoxyglucose and 18F-fluorocholine PET/CT to predict early recurrence of unifocal hepatocellular carcinoma after surgical resection.
Fartoux L; Balogova S; Nataf V; Kerrou K; Huchet V; Rosmorduc O; Talbot JN
Nucl Med Commun; 2012 Jul; 33(7):757-65. PubMed ID: 22504293
[TBL] [Abstract][Full Text] [Related]
54. Positioning of 18F-fluorodeoxyglucose-positron emission tomography imaging in the management algorithm of hepatocellular carcinoma.
Kawamura E; Shiomi S; Kotani K; Kawabe J; Hagihara A; Fujii H; Uchida-Kobayashi S; Iwai S; Morikawa H; Enomoto M; Murakami Y; Tamori A; Kawada N
J Gastroenterol Hepatol; 2014 Sep; 29(9):1722-7. PubMed ID: 24730671
[TBL] [Abstract][Full Text] [Related]
55. 18F-FDG PET in Liver Transplantation Setting of Hepatocellular Carcinoma: Predicting Histology?
Bailly M; Venel Y; Orain I; Salamé E; Ribeiro MJ
Clin Nucl Med; 2016 Mar; 41(3):e126-9. PubMed ID: 26545024
[TBL] [Abstract][Full Text] [Related]
56. Composite criteria using clinical and FDG PET/CT factors for predicting recurrence of hepatocellular carcinoma after living donor liver transplantation.
Kang YK; Choi JY; Paeng JC; Kim YI; Kwon HW; Cheon GJ; Suh KS; Kwon CHD; Lee DS; Kang KW
Eur Radiol; 2019 Nov; 29(11):6009-6017. PubMed ID: 31115626
[TBL] [Abstract][Full Text] [Related]
57. Value of 18F-FDG PET/CT in detecting viable tumour and predicting prognosis of hepatocellular carcinoma after TACE.
Song HJ; Cheng JY; Hu SL; Zhang GY; Fu Y; Zhang YJ
Clin Radiol; 2015 Feb; 70(2):128-37. PubMed ID: 25459673
[TBL] [Abstract][Full Text] [Related]
58. Low glucose metabolism in hepatocellular carcinoma with GPC3 expression.
Li YC; Yang CS; Zhou WL; Li HS; Han YJ; Wang QS; Wu HB
World J Gastroenterol; 2018 Jan; 24(4):494-503. PubMed ID: 29398870
[TBL] [Abstract][Full Text] [Related]
59. Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with Barcelona Clinic Liver Cancer stages 0 and A hepatocellular carcinomas: a multicenter retrospective cohort study.
Hyun SH; Eo JS; Lee JW; Choi JY; Lee KH; Na SJ; Hong IK; Oh JK; Chung YA; Song BI; Kim TS; Kim KS; Moon DH; Yun M
Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1638-45. PubMed ID: 26936852
[TBL] [Abstract][Full Text] [Related]
60. Clinical Value of 18F-FDG PET/CT in Detecting Adrenal Metastasis in Patients with Hepatocellular Carcinoma.
Lin Y; Jeng LB; Wang HY; Tsai SC; Lin WY; Kao CH
Technol Cancer Res Treat; 2015 Oct; 14(5):593-9. PubMed ID: 24945368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
